Drug Repurposing Service Providers Market, 2020-2030 by Roots Analysis

Category: Health

Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed / shelved drug development programs Roots Analysis is pleased to announce the publication of its recent study, titled, “Drug Repurposing Service Providers Market, 2020-2030.” The report features an extensive study of the current market landscape and future opportunities for players offering services for repurposing / repositioning / reprofiling of drug candidates. It features an in-depth analysis, highlighting the capabilities of various service providers engaged in this domain. In addition to other elements, the study includes:  A detailed assessment of the current market landscape of companies offering drug repurposing services.  Elaborate profiles of key players that specialize in offering services for the development of repurposed drugs.  An analysis of the partnerships that have been established in this domain, in the recent past.  An analysis of the initiatives of big biopharma players engaged in this domain.  A detailed analysis of more than 1,700 terminated / withdrawn / suspended clinical studies of the drug candidates.  A detailed analysis on the cost saving potential of drug repurposing approaches, as compared to the traditional de novo drug development methods.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below) To Request for sample - https://www.rootsanalysis.com/reports/drug-repurposing-service-provides/request-sample.html